Neopharm   Report issue

For profit Phase 2
Founded: Blainville Canada (1990)
Status: Acquired by Insys Therapeutics Inc (2010)

Organization Overview

First Clinical Trial
2018
NCT03406611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Orphan Technologies Ltd